Peptides for med-spa procurement, bulk active or private-label finished product.

Yes. Cosmetic-grade peptides ship with the INCI name on the SDS, Copper Tripeptide-1 (GHK-Cu), Acetyl Octapeptide-3 (Snap-8), Palmitoyl Pentapeptide-4 (Matrixyl), and equivalents for the rest of the cosmetic catalog. The INCI documentation supports finished-product notification in EU CPNP, FDA cosmetic monograph workflows, and equivalent registries. The cosmetic-grade specification sheet is separate from the research-grade COA and includes the documentation depth your finished-product regulatory pathway requires.

End-to-end: formulation development (or porting an existing formula to our manufacturing line), stability testing in the specific carrier system (typical accelerated 40°C/75% RH + real-time 25°C/60% RH protocols), primary packaging sourcing (airless-pump bottles, jars, ampoules, multi-dose vials), secondary packaging (brand cartons, IFU/insert design, regulatory disclaimers per destination market), and finished-goods QC release. Typical first-run MOQ is 3,000 units per SKU; lower MOQ available for pilot launches with adjusted pricing. Full timeline 8-14 weeks from signed brief to first shipment.

Both. Bulk lyophilized B-12, L-Carnitine, and MIC-trio components ship in standard mg fills. Pre-mixed aqueous formulations (1 mg/mL B-12 solution, 600 mg / 1200 mg L-Carnitine solution, Lipo-C aqueous blends at 10 mL) are also available, these are commonly used by med-spa clinics that prefer ready-to-use IM injection format. Custom blends with specific MIC ratios or alternative B-vitamin forms (methylcobalamin instead of cyanocobalamin) are available through the OEM service.

Lemon Bottle and similar Korean-origin aesthetic injectables have varied regulatory acceptance: approved or tolerated in several Asian markets where they originate; off-label or grey-market in the UK and parts of EU; prohibited or strongly restricted in the US. The composition uses ingredients that are individually established but the finished-product approval status is jurisdiction-specific. We distribute only to qualified buyers who have verified the product's regulatory status in their destination market and have the appropriate aesthetic-injectable licensing. Specify the destination at quote stage so our regulatory team can confirm the procurement fit.

The realistic launch timeline depends on how much formulation work the brand brings versus needs developed from scratch. Brand brings an existing formula plus packaging design: 8-10 weeks from signed brief to first shipment. Brand brings a concept plus reference products but needs formulation work: 12-16 weeks. Brand starts from scratch with no prior formulation: 16-24 weeks because the stability-testing protocol becomes the critical-path constraint. Recurring orders after first launch compress to 4-8 weeks against forecast. Discuss the launch timeline at quote stage so we can calibrate the development workflow accordingly.